3B BlackBio Dx Ltd

532067

Summary

Fair Value Assessment
Overvalued (28% Premium)
Fair ValueQ1,468.83UncertaintyHigh
Close Price1,883.65Feb 21, 2025
Market Closed
1,883.65
Price Down by 3.70 | 0.20 %
Previous Close
1,883.65
Day Range
1,850.10 – 1,907.90
Year Range
695.00 – 2,350.00
Bid / Ask
Market Cap
16.2 Bil
Volume / Average
1.7 k / 8.6 k
Beta (5-Year)
1.28
Shares Outstanding
8.58 Mil
Primary Exchange
Bombay Stock Exchange

Business Description
3B BlackBio Dx Ltd is an Indian company specializing in PCR-based Molecular Diagnostic Kits. The company is involved in designing, developing, manufacturing, and commercializing PCR-based Molecular Diagnostic kits, PCR Enzymes, and PCR Reagents.
Contact
7-C, Industrial Area Govindpura, Bhopal, MP 462023
T +91 7552586536
www.3bblackbio.com opens in a new tab
Sector
Healthcare
Industry
Biotechnology
Most Recent Earnings
Dec 31, 2024
Fiscal Year End
Mar 31, 2025
Employees
76

Key Metrics

Income Statement (in Mil, except ratios)
12/31/2024
03/2024
03/2023
03/2022
03/2021
03/2020
Revenue
969.72 741.25 618.36 806.46 2,267.42 288.75
Revenue Growth %
40.06% 19.87% -23.32% -64.43% 685.26% 24.05%
Gross Profit
727.97 522.78 439.14 490.23 1,751.71 156.14
Gross Profit Margin %
73.70% 70.53% 71.02% 60.79% 77.26% 54.07%
Operating Income
512.75 322.39 282.82 364.26 1,493.73 87.81
Operating Margin %
50.44% 43.49% 45.74% 45.17% 65.88% 30.41%
EBIT
523.24 381.26 355.08 433.30 1,522.64 103.86
EBIT Margin %
58.63% 51.43% 57.42% 53.73% 67.15% 35.97%
EBITDA
534.89 391.83 363.71 440.01 1,528.80 109.22
EBITDA Margin %
59.93% 52.86% 58.82% 54.56% 67.42% 37.83%
Net Income
474.90 321.01 259.37 322.00 1,138.69 76.87
Net Profit Margin %
48.70% 43.31% 41.94% 39.93% 50.22% 26.62%
Basic EPS
56.53 37.46 34.62 42.89 152.00 10.26
Diluted EPS
55.67 36.60 34.61 42.89 152.00 10.26
Normalized EPS
Total Dividends per Share
3.00 2.50 2.50 9.00 1.20
Balance Sheet (in Mil, except ratios)
09/30/2024
03/2024
03/2023
03/2022
03/2021
03/2020
Total Assets
2,689.74 2,481.05 2,140.59 1,920.91 1,935.24 448.35
Total Liabilities
193.63 226.31 181.48 200.15 452.49 105.79
Total Debt
7.73 8.51 20.29 25.30 20.04 35.20
Total Equity
2,496.12 2,254.74 1,959.11 1,720.76 1,482.75 342.56
Cash And Cash Equivalents
174.58 129.22 584.47 272.90 338.08 92.47
Working Capital
1,149.42 1,058.61 1,000.53 646.39 754.17 311.76
Shares Outstanding (Mil)
7.51 7.51 7.51
Book Value Per Share
259.88 228.06 203.81 175.88 42.77
Total Debt To Equity
0.00 0.00 0.01 0.01 0.01 0.10
Cash Flow Statement (in Mil, except ratios)
09/30/2024
03/2024
03/2023
03/2022
03/2021
03/2020
Cash From Operating Activities
403.36 269.51 229.05 373.26 975.20 70.40
Cash From Investing Activities
-306.05 -203.19 121.12 -284.44 -702.58 -6.40
Cash From Financing Activities
-33.87 -36.25 -50.07 -150.70 -15.65 8.10
Capital Expenditures
5.08 20.25 22.63 16.79 5.35
Free Cash Flow
279.08 252.07 310.70 1,130.86 76.43
Change in Cash
63.44 30.07 300.11 -61.88 256.97 72.11

Profile

There is no Key Executive Team data available.
Transaction History

Shares in Thousands
0 5 10 15 20 25 30 35 40
>
No Data Available
There is no available information for this investment.
Sep
2023
    • Buy
    • Acquisition
    • Option Exercise
    • Disposition
    • Sell
Transaction Detail
No Data Available
There is no available information for this investment.

Ownership

There is no Ownership data available.

© Copyright 2025 Morningstar, Inc. All rights reserved.
Terms of Use    Privacy Policy
© Copyright 2025 Morningstar, Inc. All rights reserved. Please read our Terms of Use above. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
As of December 1st, 2023, the ESG-related information, methodologies, tools, ratings, data and opinions contained or reflected herein are not directed to or intended for use or distribution to India-based clients or users and their distribution to Indian resident individuals or entities is not permitted, and Morningstar/Sustainalytics accepts no responsibility or liability whatsoever for the actions of third parties in this respect.
Company: Morningstar India Private Limited; Regd. Office: 9th floor, Platinum Technopark, Plot No. 17/18, Sector 30A, Vashi, Navi Mumbai – 400705, Maharashtra, India; CIN: U72300MH2004PTC245103; Telephone No.: +91-22-61217100; Fax No.: +91-22-61217200; Contact: Morningstar India Help Desk (e-mail: helpdesk.in@morningstar.com) in case of queries or grievances.
Top